Men's Health News

RSS

Anti-androgen therapy for patients with advanced prostate cancer may fuel bone metastasis

Dr Bock, under the mentorship of Distinguished Professor Dietmar Hutmacher, from QUT Centre for Biomedical Technologies, has focused her research on bone metastases from breast and prostate cancers.

7 Jul 2021

Artificial intelligence program analyzes CT scans for tell-tale signs of prostate cancer

Prostate cancer is the most diagnosed cancer and a leading cause of death by cancer in Australian men.

7 Jul 2021

Study explores the prevalence of long COVID in England

A review of long COVID studies conducted in March 2021 summarized the available literature on the persistent symptoms after acute COVID-19. The review also reported that most studies included hospitalized patients who had a higher prevalence of persistent symptoms compared to two community-based studies.

7 Jul 2021

Study shows antibody titers after natural SARS-CoV-2 infection last longer than previously thought

A recent study by researchers from the United Kingdom (UK) revealed that antibody levels associated with protection against reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are likely to last from 1.5 to 2 years on average and that the protection from severe infection may be present for several years.

7 Jul 2021

Scientists identify natural SARS-CoV-2 super immunity against 23 variants

The antibodies are capable of neutralizing a wide range of SARS-CoV-2 variants even at sub-nanomolar concentrations. In addition, the combinations of these antibodies reduce the risk of generating escape mutants in vitro. The study is published in the journal Science.

5 Jul 2021

Multimodality therapy critical for treating more aggressive prostate cancers

Men with high-risk prostate cancer with at least one additional aggressive feature have the best outcomes when treated with multiple healthcare disciplines, known as multimodality care, according to a UCLA study led by Dr. Amar Kishan, assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA and a researcher at the UCLA Jonsson Comprehensive Cancer Center.

1 Jul 2021

Can age, sex, BMI or blood group influence the immunogenicity of the Pfizer/BioNTech COVID-19 vaccine?

A group of Belgium researchers recently discuss their findings in the journal Microorganisms, which describe the influence of several factors on vaccine-induced immunogenicity.

1 Jul 2021

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

Oncotarget published "The presence of polymorphisms in genes controlling neurotransmitter metabolism and disease prognosis in patients with prostate cancer: a possible link with schizophrenia" reported that polymorphisms of neurotransmitter metabolism genes were studied in patients with prostate cancer (PC) characterized by either reduced or extended serum prostate-specific antigen doubling time corresponding to unfavorable and favorable disease prognosis respectively.

28 Jun 2021

Why is staying active important during the COVID-19 pandemic?

Working from home is no excuse to stop exercising. New research led by Akira Ogami from the University of Occupational and Environmental Health in Japan confirms that regular exercise is needed in maintaining good physical and mental health during the COVID-19 pandemic. Workers who allocated time towards exercise or some form of physical activity reported a higher health-related quality of life than people who did not.

27 Jun 2021

Evaluation of COVID-19 vaccination effects on outbreak dynamics in Japan

Among the developed nations, Japan was the last to commence vaccination (February 2021). Only 8.7% of Japanese people are fully vaccinated as of today, June 25th, 2021. Fortunately for Japan, the incidence of the disease has been much lower than in Europe or the United States. Now, a new study published on the medRxiv* preprint server analyzes the impact of vaccination on the COVID-19 outbreak in Japan

25 Jun 2021

Sleep-wake behavior predicts mental health resilience during COVID-19

Now, a group of researchers from the USA and Australia has collaborated on a study analyzing objective sleep-wake data and the effect of COVID-19 on the mental health of adults in the USA.

25 Jun 2021

Overcrowding and multigenerational housing arrangements increase SARS-CoV-2 transmission risk

Researchers at the Weill Cornell Medical College aimed to determine the role of overcrowded households as a risk factor for COVID-19. The study's objective, which appeared in the medRxiv* pre-print server, was to examine the link between overcrowded and multigenerational households and COVID-19 in New York City.

25 Jun 2021

Study: A subset of patients with localized prostate cancer may benefit from immunotherapies

In recent years, cancer immunotherapy has been effective in treating patients with immunogenic, or so-called "hot" tumors with increased levels of inflammation and the presence of immune cells in and around the tumors.

24 Jun 2021

Dopamine may help explain the gender differences in key motivating factors and autism

Dopamine is often called the “happy” or “feel-good” hormone. It can help explain both autistic behaviours and men’s need for passion in order to succeed.

24 Jun 2021

Dissatisfaction with married life increases men's risk of death from stroke and premature mortality

Dissatisfaction with married life raises the risk of dying from a cerebrovascular accident: A new Tel Aviv University study reveals that perceiving marriage as unsuccessful is a significant predictor of death from a CVA and premature death among men, no less that well-known risk factors such as smoking and lack of physical activity.

21 Jun 2021

Flinders University joins research alliance to tackle the challenges in men’s health

Flinders University has joined a ground breaking male health research alliance to create an unrivalled global entity.

21 Jun 2021

Study uncovers new mechanisms underlying lineage plasticity

Cancer cells have an uncanny ability to evolve and adapt to overcome the treatments used against them. While patient survival has been extended by modern drugs that block the production or action of male hormones that fuel prostate cancer -- androgen receptor inhibitors such as enzalutamide, apalutamide, darolutamide, and abiraterone -- eventually these drugs stop working.

21 Jun 2021

Men's Health News

Anti-androgen therapy for patients with advanced prostate cancer may fuel bone metastasis

Artificial intelligence program analyzes CT scans for tell-tale signs of prostate cancer

Study explores the prevalence of long COVID in England

Study shows antibody titers after natural SARS-CoV-2 infection last longer than previously thought

Scientists identify natural SARS-CoV-2 super immunity against 23 variants

Multimodality therapy critical for treating more aggressive prostate cancers

Can age, sex, BMI or blood group influence the immunogenicity of the Pfizer/BioNTech COVID-19 vaccine?

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

Why is staying active important during the COVID-19 pandemic?

Evaluation of COVID-19 vaccination effects on outbreak dynamics in Japan

Sleep-wake behavior predicts mental health resilience during COVID-19

Overcrowding and multigenerational housing arrangements increase SARS-CoV-2 transmission risk

Study: A subset of patients with localized prostate cancer may benefit from immunotherapies

Dopamine may help explain the gender differences in key motivating factors and autism

Dissatisfaction with married life increases men's risk of death from stroke and premature mortality

Flinders University joins research alliance to tackle the challenges in men’s health

Study uncovers new mechanisms underlying lineage plasticity

Study provides insight into factors that may contribute to men's suicide vulnerability

Study highlights need to address the mental health of new fathers

COVID-19 virus can infect the testes, hamster study shows

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News